BSE filing, NSE: ALKA. Summary written from the filing by ALFA Finder's alert engine.
Alka India Ltd: key numbers
- Share price
- ₹33.42
- Market cap
- ₹21.72 Cr
- Revenue (annual)
- ₹2.50 Cr
- Net profit (annual)
- ₹0.18 Cr
- P/E (TTM)
- 34.0×Sector 50.0×
- Promoter holding
- 73.08%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Alka India Ltd
All →AUDROC Board Meeting Date
Audroc Ltd intimated a Board meeting on November 3, 2026, to approve Q2 and H1 unaudited financial results. The trading window for designated persons is closed.
AUDROC Other Announcement
Audroc Ltd filed its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
AUDROC Preferential Issue
AUDROC Limited allotted convertible securities via a preferential issue. This allotment changes the company's capital structure as part of its ongoing fund-raising process.
- Value
- ₹80.00 Cr
AUDROC Convertible Warrants
Audroc Ltd allotted 20 crore equity shares upon converting warrants at ₹4.00 per warrant, raising ₹80 Crore capital for the company.
- Value
- ₹80.00 Cr
AUDROC Capital Structure Change
Audroc Ltd has allotted 7.50 crore fully convertible equity warrants to two non-promoter allottees. The warrants were issued at Rs. 4.00 each on a preferential basis.
- Value
- ₹30.00 Cr
- Execution
- 18 months
AUDROC Capital Structure Change
Audroc Ltd has allotted 3,75,00,000 convertible equity warrants on a preferential basis to a non-promoter investor at an issue price of ₹4.00 per warrant. This allotment constitutes a change in capital structure.
- Value
- ₹15.00 Cr
Other adverse business impact announcements
All →Spandana Sphoorty Financial Adverse Business Impact
Cyber fraud debited ₹7.80 crore from Spandana Sphoorty's bank account on November 1, 2026. The company has reported to authorities and filed an insurance claim.
- Value
- ₹7.80 Cr
Medplus Health Services Adverse Business Impact
MedPlus Health Services' subsidiary Optival Health Solutions had its drug licence suspended for five days for a Suryapet store. Expected financial impact is about Rs 1.32 lakh.
- Value
- ₹0.01 Cr
- Execution
- 05 days
Oriental Rail Infrastructure Adverse Business Impact
Oriental Rail's subsidiary Oriental Foundry had a fire at its Kutch plant on 28 October 2026. Damage is minimal, operations are unaffected and the loss is insured.
Capillary Technologies India Adverse Business Impact
Capillary Technologies received KPMG's final forensic report on a cyber-enabled payment fraud at a step-down subsidiary. Four disputed payments totalled EUR 3.04 million, about Rs.32.24 Crore.
- Value
- ₹32.24 Cr
Windlas Biotech Adverse Business Impact
Windlas Biotech disclosed a cyber security incident on 30 October 2026. It states no material impact on core operations, finances or business continuity.
Neogen Chemicals Adverse Business Impact
Neogen Chemicals reports continued fire disruption at MPP3; replacement plant partly built with trial runs underway. Recognized damage totals ₹348.16 crore; production shifted to other sites.
- Value
- ₹348.2 Cr